Read + Share
Amedeo Smart
Independent Medical Education
Konstantinopoulos PA, Cheng SC, Supko JG, Polak M, et al. Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours. Br J Cancer 2022;126:1027-1036.PMID: 34887522
Email
LinkedIn
Facebook
Twitter
Privacy Policy